CD274 and prostate carcinoma: Various mechanisms are similar, as for example, Zhang et al. found that RELB (a critical regulon) could facilitate cellular proliferation and angiogenesis in both prostate cancer and gliomas and could also increase PD-L1 in prostate tumors [64,70].